Loading...
Treatment of Non-Small-Cell Lung Cancer with Erlotinib following Gefitinib-Induced Hepatotoxicity: Review of 8 Clinical Cases
Objective. Gefitinib often induces liver damage. A few reports have described that the subsequent administration of erlotinib was associated with less hepatotoxicity, but the safety and efficacy of this treatment are still not fully investigated. Therefore, we evaluated retrospectively the patients...
Na minha lista:
| Udgivet i: | Lung Cancer Int |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Hindawi Publishing Corporation
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4437396/ https://ncbi.nlm.nih.gov/pubmed/26316933 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/354657 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|